The Ministry of Health, in collaboration with the Ministry of Finance and the National Bank of Ethiopia, provides local pharmaceutical manufacturers with priority foreign currency allocation covering up to 55% of their foreign exchange needs.
The Ethiopian pharmaceutical market is estimated at $1.2 billion to $1.5 billion, having expanded at a Compound Annual Growth Rate (CAGR) of approximately 10% to 12% in recent years.
The government developed the 270-hectare Kilinto Industrial Park (Kilinto Special Economic Zone) in Addis Ababa, recognized as Africa's first dedicated industrial park specifically designed for pharmaceutical manufacturing.
The Ethiopian Pharmaceuticals Supply Service (EPSS) procures and distributes pharmaceutical and medical supplies valued at over ETB 25 billion–30 billion annually (~$350 million–$500 million).
Imports account for 80%–85% of total supply ($700M–$1B annually).
Public health facility availability for essential medicines stands at 75%–85%.